• Search
      • Search Interactions Search Categories
    • Browse
      • Browse Categories Browse Sources
    • Information
      • About Publications Interaction Types & Directionalities Interaction Score & Query Score API Documentation FAQ Known Data Clients News Contact
    • Downloads
      • Data Source Code

RESINIFERATOXIN Drug Record

  • Summary
  • Interactions
  • Claims
  • RESINIFERATOXIN chembl:CHEMBL448382

    Alternate Names:

    RESINIFERATOXIN

    Drug Info:

    FDA Approval not approved
    Drug Class small molecule
    Drug Indications for treatment of interstitial cystitis,antiincontinence agent
    (0 More Sources)

    Publications:

    Nishihara K et al., 2002, Sensitizing effects of lafutidine on CGRP-containing afferent nerves in the rat stomach., Br J Pharmacol
    Szallasi A et al., 1990, Resiniferatoxin and its analogs provide novel insights into the pharmacology of the vanilloid (capsaicin) receptor., Life Sci
    Szallasi A et al., 1993, Characterization of a peripheral vanilloid (capsaicin) receptor in the urinary bladder of the rat., Life Sci
    Farkas-Szallasi et al., 1995, Increased levels of GMAP, VIP and nitric oxide synthase, and their mRNAs, in lumbar dorsal root ganglia of the rat following systemic resiniferatoxin treatment., Neuroreport
  • RESINIFERATOXIN   TRPV1

    Interaction Score: 4.18

    Interaction Types & Directionality:
    activator (activating)

    Interaction Info:
    Trial Name resiniferatoxin, RTX
    Novel drug target Established target

    PMIDs:
    11906962 2174484 8483387


    Sources:
    TdgClinicalTrial TTD

  • RESINIFERATOXIN   NOS1

    Interaction Score: 1.63

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    8595209


    Sources:
    NCI

  • TdgClinicalTrial: RESINIFERATOXIN

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications for treatment of interstitial cystitis,antiincontinence agent
    Drug Class small molecule
    FDA Approval not approved

    Publications:

  • NCI: RESINIFERATOXIN

    • Version: 14-September-2017

    Alternate Names:
    C1214 NCI drug code

    Drug Info:

    Publications:
    Farkas-Szallasi et al., 1995, Increased levels of GMAP, VIP and nitric oxide synthase, and their mRNAs, in lumbar dorsal root ganglia of the rat following systemic resiniferatoxin treatment., Neuroreport

  • TTD: Resiniferatoxin

    • Version: 2020.06.01

    Alternate Names:
    D05XJW TTD Drug ID

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL448382

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

Disclaimer: This resource is intended for purely research purposes. It should not be used for emergencies or medical or professional advice.

A finding of a drug-gene interaction or potentially druggable category does not necessarily indicate effectiveness (or lack thereof) of any drug or treatment regimen. A finding of no interaction or no potentially druggable category does not necessarily indicate lack of effectiveness of any drug or treatment regimen. Drug-gene interactions or potentially druggable categories are not presented in ranked order of potential or predicted efficacy.

The dgidb.org website does not provide any medical or healthcare products, services or advice, and is not for medical emergencies or urgent situations. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY. Information contained on this website is not a substitute for a doctor's medical judgment or advice. We recommend that you discuss your specific, individual health concerns with your doctor or health care professional.

DGIdb (v4.2.0 - sha1 afd9f30b) • Last updated 2020-10-21